| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |